메뉴 건너뛰기




Volumn 39, Issue 6, 2004, Pages 1673-1682

Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; URSODEOXYCHOLIC ACID;

EID: 2542622930     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20238     Document Type: Article
Times cited : (55)

References (44)
  • 2
    • 0020211196 scopus 로고
    • Cystic fibrosis: Its influence on the liver, biliary tree, and bile salt metabolism
    • Isenberg JN. Cystic fibrosis: its influence on the liver, biliary tree, and bile salt metabolism. Semin Liver Dis 1982;2:302-313.
    • (1982) Semin Liver Dis , vol.2 , pp. 302-313
    • Isenberg, J.N.1
  • 4
    • 0035737827 scopus 로고    scopus 로고
    • Liver disease in children with cystic fibrosis
    • Diwakar V, Pearson L, Beath S. Liver disease in children with cystic fibrosis. Paediatr Respir Rev 2001;2:340-349.
    • (2001) Paediatr Respir Rev , vol.2 , pp. 340-349
    • Diwakar, V.1    Pearson, L.2    Beath, S.3
  • 6
    • 0028212786 scopus 로고
    • Analysis of risk factors for the development of liver disease associated with cystic fibrosis
    • Colombo C, Apostolo MG, Ferrari M, Seia M, Genoni S, Giunta A, et al. Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr 1994;124:393-399.
    • (1994) J Pediatr , vol.124 , pp. 393-399
    • Colombo, C.1    Apostolo, M.G.2    Ferrari, M.3    Seia, M.4    Genoni, S.5    Giunta, A.6
  • 8
    • 0024424270 scopus 로고
    • Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
    • Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073 [erratum: Science 1989;245:1437].
    • (1989) Science , vol.245 , pp. 1066-1073
    • Riordan, J.R.1    Rommens, J.M.2    Kerem, B.3    Alon, N.4    Rozmahel, R.5    Grzelczak, Z.6
  • 9
    • 0006294996 scopus 로고
    • Erratum
    • Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073 [erratum: Science 1989;245:1437].
    • (1989) Science , vol.245 , pp. 1437
  • 10
    • 0026665209 scopus 로고
    • Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: A dose-response study
    • Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, et al. Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. HEPATOLOGY 1992;16:924-930.
    • (1992) Hepatology , vol.16 , pp. 924-930
    • Colombo, C.1    Crosignani, A.2    Assaisso, M.3    Battezzati, P.M.4    Podda, M.5    Giunta, A.6
  • 11
    • 0027969208 scopus 로고
    • Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: A randomized, placebo-controlled, crossover trial
    • Merli M, Bertasi S, Servi R, Diamanti S, Martino F, De Santis A, et al. Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: a randomized, placebo-controlled, crossover trial. J Pediatr Gastroenterol Nutr 1994;19:198-203.
    • (1994) J Pediatr Gastroenterol Nutr , vol.19 , pp. 198-203
    • Merli, M.1    Bertasi, S.2    Servi, R.3    Diamanti, S.4    Martino, F.5    De Santis, A.6
  • 12
    • 19144371795 scopus 로고    scopus 로고
    • Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double-blind multicenter trial
    • The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis
    • Colombo C, Battezzati PM, Podda M, Bettinardi N, Giunta A. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. HEPATOLOGY 1996;23:1484-1490.
    • (1996) Hepatology , vol.23 , pp. 1484-1490
    • Colombo, C.1    Battezzati, P.M.2    Podda, M.3    Bettinardi, N.4    Giunta, A.5
  • 13
  • 14
    • 0030847768 scopus 로고    scopus 로고
    • Ursodeoxycholic acid improves cholestasis in infants with cystic fibrosis
    • Scher H, Bishop WP, McCray PB Jr. Ursodeoxycholic acid improves cholestasis in infants with cystic fibrosis. Ann Pharmacother 1997;31:1003-1005.
    • (1997) Ann Pharmacother , vol.31 , pp. 1003-1005
    • Scher, H.1    Bishop, W.P.2    McCray Jr., P.B.3
  • 15
    • 0031049399 scopus 로고    scopus 로고
    • Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis
    • Jacquemin E, Hermans D, Myara A, Habes D, Debray D, Hadchouel M, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. HEPATOLOGY 1997;25:519-523.
    • (1997) Hepatology , vol.25 , pp. 519-523
    • Jacquemin, E.1    Hermans, D.2    Myara, A.3    Habes, D.4    Debray, D.5    Hadchouel, M.6
  • 16
    • 0031982747 scopus 로고    scopus 로고
    • A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease
    • Lindblad A, Glaumann H, Strandvik B. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. HEPATOLOGY 1998; 27:166-174.
    • (1998) Hepatology , vol.27 , pp. 166-174
    • Lindblad, A.1    Glaumann, H.2    Strandvik, B.3
  • 17
    • 0032878641 scopus 로고    scopus 로고
    • Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease
    • Colombo C, Crosignani A, Battezzati PM, Castellani MR, Comi S, Melzi ML, et al. Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease. J Hepatol 1999;31: 672-677.
    • (1999) J Hepatol , vol.31 , pp. 672-677
    • Colombo, C.1    Crosignani, A.2    Battezzati, P.M.3    Castellani, M.R.4    Comi, S.5    Melzi, M.L.6
  • 19
    • 84921431266 scopus 로고    scopus 로고
    • Ursodeoxycholic acid for cystic fibrosis-related liver disease
    • Cheng K, Ashby D, Smyth R. Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database Syst Rev 2000;(2):CD000222.
    • (2000) Cochrane Database Syst Rev , Issue.2
    • Cheng, K.1    Ashby, D.2    Smyth, R.3
  • 20
    • 0014783008 scopus 로고
    • Bile acid concentrations in serum during infancy and childhood
    • Sandberg DH. Bile acid concentrations in serum during infancy and childhood. Pediatr Res 1970;4:262-267.
    • (1970) Pediatr Res , vol.4 , pp. 262-267
    • Sandberg, D.H.1
  • 21
    • 0015917878 scopus 로고
    • Malabsorption of bile acids in children with cystic fibrosis
    • Weber AM, Roy CC, Morin CL, Lasalle R. Malabsorption of bile acids in children with cystic fibrosis. N Engl J Med 1973;289:1001-1005.
    • (1973) N Engl J Med , vol.289 , pp. 1001-1005
    • Weber, A.M.1    Roy, C.C.2    Morin, C.L.3    Lasalle, R.4
  • 22
    • 0018843162 scopus 로고
    • Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis
    • Arborgh B, Eklund A, Norman A, Strandvik B. Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis. Scand J Gastroenterol 1980;15:73-80.
    • (1980) Scand J Gastroenterol , vol.15 , pp. 73-80
    • Arborgh, B.1    Eklund, A.2    Norman, A.3    Strandvik, B.4
  • 23
    • 0021910146 scopus 로고
    • Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis
    • Strandvik B, Samuelson K. Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis. Scand J Gastroenterol 1985;20:381-384.
    • (1985) Scand J Gastroenterol , vol.20 , pp. 381-384
    • Strandvik, B.1    Samuelson, K.2
  • 25
    • 0025193141 scopus 로고
    • Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration
    • Nakagawa M, Colombo C, Setchell KDR. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. HEPATOLOGY 1990; 12:322-334.
    • (1990) Hepatology , vol.12 , pp. 322-334
    • Nakagawa, M.1    Colombo, C.2    Setchell, K.D.R.3
  • 26
    • 0036095120 scopus 로고    scopus 로고
    • The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease
    • Lewindon PJ, Pereira TN, Hoskins AC, Bridle KR, Williamson RM, Shepherd RW, et al. The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. Am J Pathol 2002;160: 1705-1715.
    • (2002) Am J Pathol , vol.160 , pp. 1705-1715
    • Lewindon, P.J.1    Pereira, T.N.2    Hoskins, A.C.3    Bridle, K.R.4    Williamson, R.M.5    Shepherd, R.W.6
  • 27
    • 0026072529 scopus 로고
    • Classification of chronic viral hepatitis: A need for reassessment
    • Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-374.
    • (1991) J Hepatol , vol.13 , pp. 372-374
    • Scheuer, P.J.1
  • 28
    • 0030028096 scopus 로고    scopus 로고
    • Performance characteristics of reversed-phase bonded silica cartridges for serum bile acid extraction
    • Rodrigues CM, Setchell KDR. Performance characteristics of reversed-phase bonded silica cartridges for serum bile acid extraction. Biomed Chromatogr 1996;10:1-5.
    • (1996) Biomed Chromatogr , vol.10 , pp. 1-5
    • Rodrigues, C.M.1    Setchell, K.D.R.2
  • 30
    • 0028933933 scopus 로고
    • Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children
    • Poupon R, Poupon RE. Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children. Pharmacol Ther 1995;66:1-15.
    • (1995) Pharmacol Ther , vol.66 , pp. 1-15
    • Poupon, R.1    Poupon, R.E.2
  • 31
    • 0027998655 scopus 로고
    • Pharmacology of ursodeoxycholic acid, an enterohepatic drug
    • Hofmann AF. Pharmacology of ursodeoxycholic acid, an enterohepatic drug. Scand J Gastroenterol Suppl 1994;204:1-15.
    • (1994) Scand J Gastroenterol Suppl , vol.204 , pp. 1-15
    • Hofmann, A.F.1
  • 32
    • 0027414207 scopus 로고
    • Formation of 7 alpha- and 7 beta-hydroxylated bile acid precursors from 27-hydroxycholesterol in human liver microsomes and mitochondria
    • Shoda J, Toll A, Axelson M, Pieper F, Wikvall K, Sjovall J. Formation of 7 alpha- and 7 beta-hydroxylated bile acid precursors from 27-hydroxycholesterol in human liver microsomes and mitochondria. HEPATOLOGY 1993; 17:395-403.
    • (1993) Hepatology , vol.17 , pp. 395-403
    • Shoda, J.1    Toll, A.2    Axelson, M.3    Pieper, F.4    Wikvall, K.5    Sjovall, J.6
  • 34
    • 0036828271 scopus 로고    scopus 로고
    • Functional expression of the canalicular bile salt export pump of human liver
    • Noe J, Stieger B, Meier PJ. Functional expression of the canalicular bile salt export pump of human liver. Gastroenterology 2002;123:1659-1666.
    • (2002) Gastroenterology , vol.123 , pp. 1659-1666
    • Noe, J.1    Stieger, B.2    Meier, P.J.3
  • 35
    • 0034949811 scopus 로고    scopus 로고
    • Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver
    • Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Pojer C, Zenz R, et al. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 2001;121: 170-183.
    • (2001) Gastroenterology , vol.121 , pp. 170-183
    • Fickert, P.1    Zollner, G.2    Fuchsbichler, A.3    Stumptner, C.4    Pojer, C.5    Zenz, R.6
  • 36
    • 0036322124 scopus 로고    scopus 로고
    • Ursodeoxycholic acid (UDCA) prevents DCA effects on male mouse liver via up-regulation of CYP and preservation of BSEP activities
    • Paolini M, Pozzetti L, Montagnani M, Potenza G, Sabatini L, Antelli A, et al. Ursodeoxycholic acid (UDCA) prevents DCA effects on male mouse liver via up-regulation of CYP and preservation of BSEP activities. HEPATOLOGY 2002;36:305-314.
    • (2002) Hepatology , vol.36 , pp. 305-314
    • Paolini, M.1    Pozzetti, L.2    Montagnani, M.3    Potenza, G.4    Sabatini, L.5    Antelli, A.6
  • 37
    • 0036725044 scopus 로고    scopus 로고
    • Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited
    • Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. HEPATOLOGY 2002;36:525-531.
    • (2002) Hepatology , vol.36 , pp. 525-531
    • Paumgartner, G.1    Beuers, U.2
  • 38
    • 0033172845 scopus 로고    scopus 로고
    • Review article: Mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases
    • Trauner M, Graziadei IW. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases. Aliment Pharmacol Ther 1999;13:979-996.
    • (1999) Aliment Pharmacol Ther , vol.13 , pp. 979-996
    • Trauner, M.1    Graziadei, I.W.2
  • 39
    • 0022358795 scopus 로고
    • Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis
    • Robb TA, Davidson GP, Kirubakaran C. Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis. Gut 1985;26:1246-1256.
    • (1985) Gut , vol.26 , pp. 1246-1256
    • Robb, T.A.1    Davidson, G.P.2    Kirubakaran, C.3
  • 40
    • 0029126559 scopus 로고
    • Ursodeoxycholate increases cytosolic calcium concentration and activates Cl-currents in a biliary cell line
    • Shimokura GH, McGill JM, Schlenker T, Fitz JG. Ursodeoxycholate increases cytosolic calcium concentration and activates Cl-currents in a biliary cell line. Gastroenterology 1995;109:965-972.
    • (1995) Gastroenterology , vol.109 , pp. 965-972
    • Shimokura, G.H.1    McGill, J.M.2    Schlenker, T.3    Fitz, J.G.4
  • 41
    • 0027325467 scopus 로고
    • Abnormal expression of anion exchanger genes in primary biliary cirrhosis
    • Prieto J, Qian C, Garcia N, Diez J, Medina JF. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 1993; 105:572-578.
    • (1993) Gastroenterology , vol.105 , pp. 572-578
    • Prieto, J.1    Qian, C.2    Garcia, N.3    Diez, J.4    Medina, J.F.5
  • 43
    • 0027372350 scopus 로고
    • Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats
    • Azer SA, Murray M, Farrell GC, Stacey NH. Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats. HEPATOLOGY 1993;18:1224-1231.
    • (1993) Hepatology , vol.18 , pp. 1224-1231
    • Azer, S.A.1    Murray, M.2    Farrell, G.C.3    Stacey, N.H.4
  • 44
    • 0029879867 scopus 로고    scopus 로고
    • Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease
    • Azer SA, Coverdale SA, Byth K, Farrell GC, Stacey NH. Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease. J Gastroenterol Hepatol 1996;11:208-215.
    • (1996) J Gastroenterol Hepatol , vol.11 , pp. 208-215
    • Azer, S.A.1    Coverdale, S.A.2    Byth, K.3    Farrell, G.C.4    Stacey, N.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.